AlphaStar Capital Management LLC Increases Position in Kenvue Inc. (NYSE:KVUE)

AlphaStar Capital Management LLC increased its stake in shares of Kenvue Inc. (NYSE:KVUE) by 102.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,805 shares of the company’s stock after purchasing an additional 11,549 shares during the quarter. AlphaStar Capital Management LLC’s holdings in Kenvue were worth $487,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Empirical Finance LLC lifted its position in Kenvue by 3.1% during the fourth quarter. Empirical Finance LLC now owns 26,127 shares of the company’s stock valued at $558,000 after acquiring an additional 786 shares during the last quarter. Empowered Funds LLC lifted its holdings in shares of Kenvue by 19.2% during the 4th quarter. Empowered Funds LLC now owns 178,009 shares of the company’s stock valued at $3,800,000 after purchasing an additional 28,638 shares during the last quarter. Farmers & Merchants Investments Inc. lifted its holdings in shares of Kenvue by 1.4% during the 4th quarter. Farmers & Merchants Investments Inc. now owns 73,910 shares of the company’s stock valued at $1,578,000 after purchasing an additional 1,000 shares during the last quarter. Apollon Wealth Management LLC boosted its position in shares of Kenvue by 16.5% in the 4th quarter. Apollon Wealth Management LLC now owns 11,701 shares of the company’s stock worth $250,000 after purchasing an additional 1,653 shares in the last quarter. Finally, William Allan Corp grew its stake in Kenvue by 16.3% during the 4th quarter. William Allan Corp now owns 44,032 shares of the company’s stock worth $940,000 after buying an additional 6,173 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on KVUE. Royal Bank of Canada reissued a “sector perform” rating and issued a $24.00 price target on shares of Kenvue in a report on Monday, February 3rd. Bank of America lifted their target price on shares of Kenvue from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Tuesday, October 22nd. Deutsche Bank Aktiengesellschaft lowered shares of Kenvue from a “buy” rating to a “hold” rating and cut their price target for the company from $25.00 to $24.00 in a research note on Thursday, December 12th. Barclays lowered their price objective on shares of Kenvue from $23.00 to $21.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Finally, Citigroup cut their target price on Kenvue from $25.00 to $21.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 15th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $23.00.

Kenvue Stock Performance

NYSE KVUE opened at $20.23 on Monday. The firm has a market capitalization of $38.79 billion, a P/E ratio of 38.17, a PEG ratio of 2.16 and a beta of 1.45. The stock has a 50-day simple moving average of $21.54 and a two-hundred day simple moving average of $21.97. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $24.46.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, meeting the consensus estimate of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. On average, equities analysts forecast that Kenvue Inc. will post 1.05 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be paid a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 4.05%. The ex-dividend date is Wednesday, February 12th. Kenvue’s dividend payout ratio is currently 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.